Related references
Note: Only part of the references are listed.The effect of diabetes mellitus on rat mandibular bone formation and microarchitecture
Mona A. Abbassy et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men
Jenny M. Kindblom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
B. A. Lenart et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats
Hideki Fujii et al.
BONE (2008)
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
Brett A. Lenart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
Mathieu Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis
Selculk Dagdelen et al.
ADVANCES IN THERAPY (2007)
Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women
Zehra Berberoglu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: A possible role of oxidative stress
Yasuhiro Hamada et al.
BONE (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years
Sydney Bonnick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus
P Gerdhem et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone metabolism in male patients with type 2 diabetes
L Achemlal et al.
CLINICAL RHEUMATOLOGY (2005)
Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women - The fracture intervention trial
THM Keegan et al.
DIABETES CARE (2004)
Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone defect in spontaneously diabetic rats
N Follak et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Octreotide abolishes the acute decrease in bone turnover in response to oral glucose
JA Clowes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures
T Mashiba et al.
BONE (2001)
Share Paper
